Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $378.5600 (1%) ($374.1450 - $381.3500) on Tue. Aug. 21, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.6% (three month average) | RSI | 56 | Latest Price | $378.5600(1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.7% a day on average for past five trading days. | Weekly Trend | REGN declines -2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(50%) IVW(43%) IWF(43%) QQQ(43%) | Factors Impacting REGN price | REGN will decline at least -0.8% in a week (0% probabilities). VXX(-12%) UUP(-11%) TLT(-7%) IFRA(-6%) VIXM(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.8% (StdDev 1.6%) | Hourly BBV | 0 () | Intraday Trend | 1.1% | | | |
|
5 Day Moving Average | $372.25(1.7%) | 10 Day Moving Average | $371.02(2.03%) | 20 Day Moving Average | $375.35(0.86%) | To recent high | -4.6% | To recent low | 28.9% | Market Cap | $40.138b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |